Literature DB >> 6187686

Enhancement of antigen-specific suppression by muramyl dipeptide.

T A Ferguson, N J Krieger, A Pesce, J G Michael.   

Abstract

The effect of the synthetic adjuvant MDP (N-acetyl-muramyl-L-alanyl-D-isoglu-tamine) on the generation of antigen-specific suppression was investigated. Suppression of the anti-bovine serum albumin response, which was achieved by intravenous administration of a peptic fragment of the antigen, was greatly enhanced by simultaneous administration of MDP. Induction of suppression by a combination of bovine serum albumin fragments and MDP was found to be antigen specific and appeared to occur via the generation of antigen-specific suppressor T cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6187686      PMCID: PMC348020          DOI: 10.1128/iai.39.2.800-806.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Fragments of bovine serum albumin produced by limited proteolysis. Isolation and characterization of peptic fragments.

Authors:  R C Feldhoff; T Peters
Journal:  Biochemistry       Date:  1975-10-07       Impact factor: 3.162

2.  Modulation of the immune response by a synthetic adjuvant and analogs.

Authors:  L Chedid; F Audibert; P Lefrancier; J Choay; E Lederer
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

3.  Distinctive adjuvanticity of synthetic analogs of mycobacterial water-soluble components.

Authors:  F Audibert; L Chédid; P Lefrancier; J Choay
Journal:  Cell Immunol       Date:  1976-02       Impact factor: 4.868

4.  Target cells for the activity of a synthetic adjuvant: muramyl dipeptide.

Authors:  I Löwy; C Bona; L Chedid
Journal:  Cell Immunol       Date:  1977-03-01       Impact factor: 4.868

5.  Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives.

Authors:  F Ellouz; A Adam; R Ciorbaru; E Lederer
Journal:  Biochem Biophys Res Commun       Date:  1974-08-19       Impact factor: 3.575

6.  Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes.

Authors:  E Engvall; P Perlmann
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

7.  The molecular classes of two homocytotropic antibodies in the mouse.

Authors:  H A Schwartz; B B Levine
Journal:  J Immunol       Date:  1973-06       Impact factor: 5.422

8.  Effect of a synthetic adjuvant on the induction of primary immune responses in T cell-depleted spleen cultures.

Authors:  J Watson; C Whitlock
Journal:  J Immunol       Date:  1978-07       Impact factor: 5.422

9.  Immunosuppressive properties of a peptic fragment of BSA.

Authors:  A Muckerheide; A J Pesce; J G Michael
Journal:  J Immunol       Date:  1977-10       Impact factor: 5.422

10.  Immunization of dissociated spleen cell cultures from normal mice.

Authors:  R I Mishell; R W Dutton
Journal:  J Exp Med       Date:  1967-09-01       Impact factor: 14.307

View more
  6 in total

1.  Adjuvants et stimulants de l'immunité: propriétés immunorégulatrices du muramyl-dipeptide, des corynébactéries anaérobies et du diéthyldithiocarbamate de sodium.

Authors:  D Archambault; G Morin
Journal:  Can Vet J       Date:  1988-01       Impact factor: 1.008

2.  The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections.

Authors:  J Drews
Journal:  Infection       Date:  1985       Impact factor: 3.553

3.  Immunoresponses to Neisseria meningitidis epitopes: in vivo analysis of immunocompetent cells involved in suppression of secondary response to phosphorylcholine.

Authors:  J Faro; R Seoane; I Lareo; A Eiras; M Schiller; B J Regueiro
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

4.  The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections.

Authors:  J Drews
Journal:  Infection       Date:  1984 Mar-Apr       Impact factor: 3.553

5.  New approaches for control of infections using synthetic or semi-synthetic constructs containing MDP.

Authors:  L Chedid; F Audibert
Journal:  Springer Semin Immunopathol       Date:  1985

6.  Immunoresponses to Neisseria meningitidis epitopes: suppression of secondary response to phosphorylcholine is carrier specific.

Authors:  J Faro; R Seoane; A Eiras; I Lareo; J Couceiro; B J Regueiro
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.